277 (Januvia 100 mg)

Generic Name: sitagliptin

This pill with imprint "277" is Brown, Round and has been identified as Januvia 100 mg. It is manufactured by Merck & Company Inc..

Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Januvia

Generic Name:

sitagliptin

Imprint:

277

Strength:

100 mg

Color:

Brown

Size:

10.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Dipeptidyl peptidase 4 inhibitors

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Merck & Company Inc.

National Drug Code (NDC):

00006-0277

Inactive Ingredients:

calcium phosphate dibasic anhydrous
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
ferric oxide red
sodium stearyl fumarate
magnesium silicate
titanium dioxide
ferric oxide yellow

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
54569-5925	A-S Medication Solutions, LLC (repackager)
54868-5840	Physicians Total Care Inc (repackager)
35356-0103	Lake Erie Medical and Surgical Supply (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.